Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments.

Gillham, R; Baker, G; Thompson, P; Birbeck, K; McGuire, A; Tomlinson, L; Eckersley, L; Silveira, C; Brown, S

Gillham, R; Baker, G; Thompson, P; Birbeck, K; McGuire, A; Tomlinson, L; Eckersley, L; Silveira, C; Brown, S.

Affiliation

Gillham R; Institute of Neurological Sciences, Southern General Hospital, Glasgow, UK.

Epilepsy Res ; 24(1): 47-55, 1996 May.

Article in En | MEDLINE | ID: mdl-8800634

Subject(s)

Anticonvulsants/adverse effects; Behavior/drug effects; Cognition Disorders/chemically induced; Cognition Disorders/psychology; Mood Disorders/chemically induced; Mood Disorders/psychology; Adolescent; Adult; Affect/drug effects; Aging/psychology; Anticonvulsants/therapeutic use; Carbamazepine/adverse effects; Carbamazepine/therapeutic use; Double-Blind Method; Epilepsy/drug therapy; Epilepsy/psychology; Fatigue/chemically induced; Fatigue/psychology; Female; Humans; Interpersonal Relations; Lamotrigine; Male; Middle Aged; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Triazines/adverse effects; Triazines/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Behavior / Cognition Disorders / Mood Disorders / Anticonvulsants Type of study: Clinical_trials / Qualitative_research Aspects: Patient_preference Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Epilepsy Res Year: 1996 Document type: Article

Search on Google

XML

PubMed Links